content_image/267573.jpg
## corporate Data/investor inforMation 

## Company Name 

Astellas Pharma Inc. 

## Head Office 

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan TEL: +81-3-3244-3000 http://www.astellas.com/en/ 

## Capital (as of March 31, 2014) 

¥103 billion 

## Representative 

yoshihiko Hatanaka Representative Director, President and CEO 

## Founded 

1923 

## Professional Institution Affiliation 

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) 

* Masafumi Nogimori (Representative Director and Chairman) was appointed Vice President of the IFPMA in November 2010. 

## Stock Exchange Listing 

Tokyo (Securities Code: 4503) 

## Independent Auditors 

Ernst & young ShinNihon LLC Hibiya Kokusai Building, 2-2-3 Uchisaiwai-cho, Chiyoda-ku, Tokyo 100-0011, Japan 

## Common Stock (as of March 31, 2014) 

<img src='content_image/267573.jpg'>

Number of shareholders: 45,857 

Astellas conducted a five-for-one stock split on April 1, 2014. As a result, authorized common stock and issued common stock increased to 9,000,000,000 shares and 2,284,823,175 shares, respectively. 

